Literature DB >> 11082091

Regular review: treatment possibilities for unstable angina.

A Manhapra1, S Borzak.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11082091      PMCID: PMC1119013          DOI: 10.1136/bmj.321.7271.1269

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  68 in total

1.  Diagnostic marker cooperative study for the diagnosis of myocardial infarction.

Authors:  J Zimmerman; R Fromm; D Meyer; A Boudreaux; C C Wun; R Smalling; B Davis; G Habib; R Roberts
Journal:  Circulation       Date:  1999-04-06       Impact factor: 29.690

2.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

3.  Prognostic value of the admission electrocardiogram in acute coronary syndromes.

Authors:  S Savonitto; D Ardissino; C B Granger; G Morando; M D Prando; A Mafrici; C Cavallini; G Melandri; T D Thompson; A Vahanian; E M Ohman; R M Califf; F Van de Werf; E J Topol
Journal:  JAMA       Date:  1999-02-24       Impact factor: 56.272

4.  Clinical outcomes of bivalirudin for ischemic heart disease.

Authors:  D F Kong; E J Topol; J A Bittl; H D White; P Théroux; V Hasselblad; R M Califf
Journal:  Circulation       Date:  1999-11-16       Impact factor: 29.690

Review 5.  Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention.

Authors:  E Boersma; K M Akkerhuis; P Théroux; R M Califf; E J Topol; M L Simoons
Journal:  Circulation       Date:  1999-11-16       Impact factor: 29.690

6.  Early dipyridamole (99m)Tc-sestamibi single photon emission computed tomographic imaging 2 to 4 days after acute myocardial infarction predicts in-hospital and postdischarge cardiac events: comparison with submaximal exercise imaging.

Authors:  K A Brown; G V Heller; R S Landin; L J Shaw; G A Beller; M J Pasquale; S B Haber
Journal:  Circulation       Date:  1999-11-16       Impact factor: 29.690

7.  ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).

Authors:  E Braunwald; E M Antman; J W Beasley; R M Califf; M D Cheitlin; J S Hochman; R H Jones; D Kereiakes; J Kupersmith; T N Levin; C J Pepine; J W Schaeffer; E E Smith; D E Steward; P Theroux; J S Alpert; K A Eagle; D P Faxon; V Fuster; T J Gardner; G Gregoratos; R O Russell; S C Smith
Journal:  J Am Coll Cardiol       Date:  2000-09       Impact factor: 24.094

8.  Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease.

Authors:  L Wallentin; B Lagerqvist; S Husted; F Kontny; E Ståhle; E Swahn
Journal:  Lancet       Date:  2000-07-01       Impact factor: 79.321

9.  Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability.

Authors:  L M Biasucci; G Liuzzo; R L Grillo; G Caligiuri; A G Rebuzzi; A Buffon; F Summaria; F Ginnetti; G Fadda; A Maseri
Journal:  Circulation       Date:  1999-02-23       Impact factor: 29.690

10.  Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial. Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators.

Authors: 
Journal:  Lancet       Date:  1999-02-06       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.